Biopharmaceuticals, or biologics, are complex medicines manufactured from living organisms, cells, or tissues rather than through chemical synthesis. Photo | Express / Vinay Madapu
Business

Budget proposes Rs 10,000 crore investment in biopharma

The minister added that semiconductor mission 2.0 will focus on producing equipment and materials designed for full-stack Indian IP (intellectual property).

PTI

NEW DELHI: Finance Minister Nirmala Sitharaman on Sunday proposed Rs 10,000 crore investment in the biopharma sector over the next five years, a move which would give a boost to the country's pharmaceuticals industry.

Biopharmaceuticals, or biologics, are complex medicines manufactured from living organisms, cells, or tissues rather than through chemical synthesis.

She also proposed interventions in six areas, including manufacturing, strategic and frontier sectors, healthcare and advanced technology.

The minister added that semiconductor mission 2.0 will focus on producing equipment and materials designed for full-stack Indian IP (intellectual property).

The India Semiconductor Mission (ISM) is a specialised, autonomous business division within Digital India Corporation under Ministry of Electronics and Information Technology (MeitY), designed to build a sustainable semiconductor and display ecosystem.

Sitharaman also announced support for mineral rich states of Odisha, Kerala, Andhra Pradesh and Tamil Nadu to establish critical mineral facilities.

She added that 'Sabka Saath, Sabka Vikas' is the third Kartavya of the government.

Finance Minister presents 'unique yuva-shakti driven budget driven by three kartavyas'

Markets trade flat in rare Sunday session as Budget 2026 keeps investors cautious

India to buy Venezuelan oil instead of Iranian crude, claims Trump

UGC in caste discrimination pickle

Four shots fired outside film maker Rohit Shetty's Mumbai residence, probe on

SCROLL FOR NEXT